Quality Quartet Registers connect Quality Quartets to their process system or unit operation “parent.”
ANDRANIK123 - STOCK.ADOBE.COM
The Quality Quartet is a proposed technical mechanism to eliminate inconsistencies and deficiencies within and between the commissioning and qualification (C&Q) and process validation (PV) lifecycles. Quality Quartets are four-component objects comprising two process and two system parts, but itemized and managed as singularities. Using a combination of International Council for Harmonisation (ICH) and International Society of Pharmaceutical Engineering (ISPE) terminology, the process parts are critical quality attribute (CQA) and critical process parameter (CPP), and the related system parts are critical aspect (CA) and critical design element (CDE). When implemented, Quality Quartets clearly demonstrate 100% connectivity between C&Q and PV datasets. They also facilitate unambiguous communication between product development and facility delivery silos, and between manufacturers and regulators.
ISPE re-issued its C&Q Baseline Guide in 2019 to take account of the global regulatory expectation for patient-centric, risk-based design and delivery of manufacturing processes and systems. The guide now runs to more than 200 pages, including appendices (1).
This paper explains the essential aspects of the guide. The guide is summarized by annotating its underlying principles and recommended workflow. Several practical recommendations are included targeted at optimizing implementation of the guide. Advantages of grouping CQAs, CPPs, CAs, and CDEs into Quality Quartets are discussed.
Click here for a PDF of this article.Cliff Campbell is senior consultant at KPC.
Pharmaceutical Technology
Vol. 47, No. 5
May 2023
Page: 53-57
When referring to this article, please cite it as Campbell, C. Quality Quartets in Risk-Based Qualification. Pharmaceutical Technology 2023 47 (5).
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.